Bya Cocer Peptides 
ennaku 13 eziyise
EBINTU BYONNNA N’AMAWULIRE GW’EBINTU EBIweereddwa KU MUTINDO GUNO BIKOZESEBWA KU KUSASANYA AMAWULIRE N’EBIKOLWA BY’OKUSOMESA.
Ebintu ebiweereddwa ku mukutu guno bigendereddwamu kunoonyereza mu kisenge (in vitro research) byokka. Okunoonyereza mu vitro (Olulattini: *mu ndabirwamu*, ekitegeeza mu bikozesebwa mu ndabirwamu) kukolebwa ebweru w’omubiri gw’omuntu. Ebintu bino si bya ddagala, tebikkiriziddwa kitongole kya Amerika ekivunaanyizibwa ku by’emmere n’eddagala (FDA), era tebirina kukozesebwa kuziyiza, kujjanjaba oba kuwonya mbeera yonna ya bujjanjabi, bulwadde oba bulwadde. Kikugirwa nnyo mu mateeka okuyingiza ebintu bino mu mubiri gw’omuntu oba ebisolo mu ngeri yonna.
Okulaba ebikwata ku Semaglutid
Semaglutid ye ddagala eriweweeza ku bulwadde bwa peptide-1 receptor agonist (GLP-1 RA) eriringa glucagon. Glucagon-like peptide-1 (GLP-1) ye hormone efulumizibwa mu butonde omubiri gw’omuntu ekola kinene mu kulungamya glucose mu musaayi. Omuwendo gwa glucose mu musaayi bw’alinnya, GLP-1 efuluma era n’etereeza emiwendo gya glucose mu musaayi ng’eyita mu nkola ez’enjawulo. Wabula mu balwadde ba ssukaali, okufulumya GLP-1 kutera obutamala oba ebivaamu tebimala. Semaglutid yeekwata ku bikwata GLP-1, n’ekoppa ebikolwa by’omubiri ebya GLP-1, bwe kityo n’ekola ebikolwa eby’obujjanjabi ku ssukaali n’okuddukanya obuzito.
Ekifaananyi 1 Obujjanjabi bw’omugejjo n’engeri gye bukwata ku kugejja
Omulimu gwa Semaglutid mu bujjanjabi bwa sukaali
Okutumbula Okufulumya Insulin
Mu mbeera z’omubiri, glucose mu musaayi bw’alinnya, obutoffaali bwa enteroendocrine mu kyenda bufulumya GLP-1. GLP-1 yeekwata ku bikwata GLP-1 ku ngulu w’obutoffaali bwa β obw’olubuto, n’ekola amakubo agawerako agalaga obubonero okwongera ku kufulumya insulini. Semaglutid era esobola okwesiba mu ngeri ey’enjawulo ku bikwata GLP-1 ku ngulu w’obutoffaali bwa β obw’olubuto, n’esitula okufulumya insulini mu ngeri eyeesigama ku bungi bwa glucose. Kino kitegeeza nti glucose mu musaayi bw’alinnya, Semaglutid atumbula bulungi okufulumya insulini okukendeeza ku glucose mu musaayi; emiwendo gya glucose mu musaayi bwe giba mu kigero ekya bulijjo, ekikolwa kyayo ku kutumbula okufulumya insulini kiba kinafu, bwe kityo ne kikendeeza ku bulabe bw’okukendeera kwa sukaali mu musaayi. Okunoonyereza kulaga nti oluvannyuma lw’okujjanjabwa ne Semaglutid, emiwendo gya insulini gy’abalwadde gitereera nnyo, era emiwendo gya glucose mu musaayi gisobola okufugibwa obulungi.
Ekifaananyi 2: Enkola eyesigamiziddwa ku buzito obw’okungulu okusinziira ku nkola ey’okussa wansi, glucose, n’enkola y’okukyusakyusa omutima. Enzijanjaba ezesigamiziddwa ku Incretin zakola dda ku mutendera ogusinga okubeera waggulu.
Okwawukanako n’ebirungo ebifulumya insulini eby’ekinnansi, nga sulfonylureas, ebisitula obutasalako okufulumya insulini awatali kulowooza ku miwendo gya glucose mu musaayi era nga biyinza okwongera ku bulabe bw’okukendeera kwa sukaali mu musaayi, Semaglutid’s glucose-concentration-dependent insulin secretion properties esobozesa okukendeeza obulungi emiwendo gya glucose mu musaayi ate nga kikendeeza nnyo ku mirundi gy’okukendeera kwa sukaali mu musaayi, n’ewa eky’okulonda ekirungi era ekikola obulungi eky’okufuga glucose mu musaayi abalwadde ba ssukaali.
Okuziyiza okufulumya kwa glucagon
Glucagon busimu obufulumizibwa obutoffaali bwa α obw’olubuto obulinnyisa emiwendo gya glucose mu musaayi, nga bukola ekintu ekikontana ne insulini. Mu balwadde ba ssukaali, okufuluma kwa glucagon kutera okusigala nga tekuziyiziddwa ne bwe kiba nti glucose mu musaayi ali waggulu. Semaglutid ekola ku bikwata GLP-1 ku butoffaali bwa α obw’olubuto okuziyiza okufulumya kwa glucagon. Okufulumya glucagon bwe kukendeera, enkola z’ekibumba eza glycogenolysis ne gluconeogenesis ziziyizibwa, ne kikendeeza ku kukola glucose munda n’okwongera okukkakkanya ku glucose mu musaayi. Bannasayansi bakakasizza nti mu balwadde ba sukaali ow’ekika eky’okubiri abajjanjabwa ne Semaglutid, emiwendo gya glucagon mu plasma gikendeera nnyo, ekikendeeza bulungi ku glucose mu kibumba era nga kikola kinene nnyo mu kutebenkeza emiwendo gya glucose mu musaayi.
Okulwawo okufulumya amazzi mu lubuto
Semaglutid ekola ku bikwata GLP-1 mu nkola y’olubuto okukendeeza ku kufuluma kw’olubuto. Okufuluma amangu mu lubuto kireetera emmere okuyingira amangu mu kyenda ekitono ekivaako glucose mu musaayi okulinnya amangu. Olw’okulwawo okufulumya amazzi mu lubuto, emmere esigala mu lubuto okumala ekiseera ekiwanvu n’eyingira mu kyenda ekitono mpola, ekivaamu okunyiga glucose mpolampola n’okuziyiza okulinnya okw’amaanyi mu glucose mu musaayi oluvannyuma lw’okulya. Ekikolwa kino kiyamba okukuuma omutindo gwa glucose mu musaayi nga gutebenkedde oluvannyuma lw’okulya n’okukendeeza ku nkyukakyuka za glucose mu musaayi. Mu kugezesebwa okumu, abalwadde abajjanjabwa ne Semaglutid baafuna okukendeera okw’amaanyi mu ntikko za glucose mu musaayi oluvannyuma lw’okulya n’enkyukakyuka entonotono eza glucose mu musaayi, ne kitereeza omutindo gw’okufuga glucose mu musaayi okutwalira awamu. Okugatta ku ekyo, okulwawo okufulumya amazzi mu lubuto kuyinza okuleeta okuwulira ng’ajjudde, okuyamba okukendeeza ku mmere gy’olya era bwe kityo ne kiyamba mu kufuga glucose mu musaayi n’okuddukanya obuzito okuva mu ngeri endala.
Ekifaananyi 3: Enkola ya Semaglutid mu kuddukanya omugejjo
Okulongoosa Enkola ya β-Cell
Obulwadde bwa sukaali obutawona busobola okwonoona obutoffaali bwa β obw’olubuto, ekivaako okukendeera mpolampola emirimu. Semaglutid tekoma ku kukendeeza ssukaali mu musaayi ng’etumbula okufulumya insulini wabula era ekuuma n’okuddaabiriza obutoffaali bwa β obw’olubuto, bwe kityo n’alongoosa enkola y’obutoffaali bwa β. Okunoonyereza kwa ssaayansi kulaga nti semaglutide eyinza okukola amakubo agamu agalaga obubonero mu butoffaali okutumbula okukula kw’obutoffaali bwa β, okuziyiza okufa kw’obutoffaali bwa β, bwe kityo n’eyongera ku muwendo n’enkola y’obutoffaali bwa β. Mu kugezesa ebisolo n’okunoonyereza okumu mu bujjanjabi, kyazuulibwa nti oluvannyuma lw’okukozesa Semaglutid, obusobozi bw’okufulumya insulini mu butoffaali bwa β bwayongera, era obuziyiza bwa insulini bwalongooka. Kino kya makulu nnyo mu kujjanjaba obulwadde bwa sukaali obw’ekika eky’okubiri okumala ebbanga eddene, kubanga kiyamba okukendeeza ku kukula kw’obulwadde n’okukendeeza ku bulabe bw’ebizibu bya sukaali.
Okukozesa Semaglutid mu Bujjanjabi bwa Ssukaali
Semaglutid erina enkola ez’enjawulo ez’okusiiga mu kujjanjaba ssukaali. Ku balwadde ba ssukaali ow’ekika eky’okubiri abaakazuulibwa, singa emiwendo gya glucose mu musaayi tegilinnya nnyo era nga tewali bizibu bya maanyi byeyoleka oba endwadde endala ez’amaanyi ezikwatagana, obujjanjabi obumu ne Semaglutid busobola okulowoozebwako. Okunoonyereza mu bujjanjabi kulaga nti abalwadde abamu abaakazuulibwa baafuna okukendeera okw’amaanyi mu miwendo gya hemoglobin A1c (HbA1c) n’okugejja oluvannyuma lw’ekiseera nga bajjanjabwa eddagala erimu. Okugeza, mu kunoonyereza okwa PIONEER series, abalwadde abajjanjabwa n’eddagala lya Semaglutid monotherapy ery’omu kamwa baafuna okukendeera okw’amaanyi mu miwendo gya HbA1c bw’ogeraageranya n’ekibinja kya placebo, nga balina obukuumi obulungi n’okugumiikiriza. Ekirungi ky’obujjanjabi obw’ekimu kiri nti yeewala akabi k’okukwatagana kw’eddagala obukwatagana n’obujjanjabi obw’omugatte, era okubuweebwa mu ngeri ennyangu kiyamba okulongoosa omulwadde okunywerera ku bujjanjabi.
Semaglutid asobola n’okukozesebwa ng’agattibwa wamu n’eddagala eddala. Bw’ogatta ne metformin, eddagala erisooka eriwonya ssukaali ow’ekika eky’okubiri, liyamba okuziyiza insulini n’okukendeeza ku glucose mu kibumba. Eddagala lino zombi lirina enkola ezikwatagana, ezisobozesa okufuga obulungi glucose mu musaayi. Okunoonyereza kulaga nti enkola eno ey’okugatta eyongera okukendeeza ku miwendo gya HbA1c era kivaamu okugejja ennyo. Okugeza, mu kugezesebwa okumu okw’obujjanjabi, abalwadde abajjanjabwa ne metformin abaagattako Semaglutid baafuna okukendeera okunene mu miwendo gya HbA1c bw’ogeraageranya n’abo abaagenda mu maaso n’obujjanjabi bwa metformin monotherapy, awamu n’okugejja okwongera, awatali kweyongera kwa maanyi mu bulabe bwa ssukaali mu musaayi. Enkola eno esaanira abalwadde abatafugibwa bulungi glucose mu musaayi nga bakozesa eddagala lya metformin monotherapy.
Ku balwadde ba sukaali ow’ekika eky’okubiri abalina glucose mu musaayi omungi era nga beetaaga obujjanjabi bwa insulini, okugattako Semaglutid ku bujjanjabi bwa insulini kiyinza okukendeeza ku ddoozi ya insulini. Mu bujjanjabi bwa insulini, abalwadde batera okufuna ensonga ng’okugejja n’okwongera ku bulabe bw’okukendeera kwa sukaali mu musaayi. Bwe kikozesebwa awamu, ebikolwa bya Semaglutid eby’okutumbula okufulumya insulini n’okuziyiza okufulumya kwa glucagon bisobola okulongoosa enkozesa ya insulini, okukendeeza ku ddoozi, era bwe kityo ne kikendeeza ku bulabe bw’okugejja n’okukendeeza ku sukaali mu musaayi. Okugeza, mu kunoonyereza okumu okw’obujjanjabi, abalwadde abaagattako Semaglutid ku bujjanjabi bwabwe obwa insulini baafuna okukendeera kwa wakati mu ddoozi ya insulini, awamu n’okwongera okukendeera mu miwendo gya HbA1c, okugejja, n’okukendeera mu mirundi gy’ebiseera by’okukendeera kwa sukaali.
Semaglutid era esobola okukozesebwa nga egattibwa wamu n’eddagala eddala eriweweeza ku ssukaali nga SGLT2 inhibitors. Ebiziyiza SGLT2 bikendeeza ku glucose mu musaayi nga bitumbula okufulumya glucose mu musulo. Okugatta bino byombi kiyinza okwongera okulongoosa okufuga kwa glucose mu musaayi nga kiyita mu nkola ez’enjawulo era kiyinza n’okuba n’ebikosa okukwatagana mu kuddukanya obuzito.
Omulimu gwa Semaglutid mu kuddukanya obuzito
Okuziyiza okwagala okulya
Semaglutid ekola ku bikwata GLP-1 mu nkola y’obusimu obw’omu makkati naddala mu hypothalamus. Hypothalamus kitundu kikulu mu mubiri okutereeza okwagala okulya n’okutebenkeza amaanyi. Oluvannyuma lw’okusiba ku bikwata GLP-1 mu hypothalamus, semaglutide esobola okulung’amya okufuluma kw’obusimu obuyitibwa neuropeptides, gamba ng’okukendeeza ku kufulumya neuropeptide Y (NPY), nga eno nsonga ya maanyi esitula okwagala okulya. Okugatta ku ekyo, Semaglutid eyinza okwongera ku mirimu gy’obusimu obuyitibwa proopiomelanocortin (POMC), nga okukola kwabwo kuleeta obubonero bw’okukkuta. Okuyita mu nkola zino, Semaglutid aziyiza bulungi okwagala okulya, ekivaako abalwadde okukendeeza ku mmere gye balya. Mu kugezesebwa mu malwaliro, abalwadde abagejjulukuka oba abagejjulukuka abakozesa Semaglutid baategeeza nti baagala okulya bakendedde n’emmere gye balya ne bakendeera, ekyateekawo omusingi gw’okugejja.
Okwongera ku nsaasaanya y’amaanyi
Ng’oggyeeko okuziyiza okwagala okulya, Semaglutid eyinza n’okukosa enkyukakyuka y’amaanyi, okwongera ku nsaasaanya y’amaanyi. Okunoonyereza kulaga nti Semaglutid eyinza okwongera ku nsaasaanya y’amaanyi ng’etereeza emirimu gy’ebitundu by’amasavu ebya kitaka. Brown adipose tissue kika kya masavu eky’enjawulo nga omulimu gwayo omukulu kwe kukozesa amaanyi okuyita mu thermogenesis. Semaglutid eyinza okukola amakubo agamu agalaga obubonero mu bitundu by’amasavu ebya kitaka, okutumbula okukyusakyusa asidi w’amasavu n’okutondebwa kw’ebbugumu. Okugatta ku ekyo, Semaglutid eyinza okukosa enkyukakyuka y’amasoboza mu bitundu by’omubiri ng’ebinywa, okwongera ku nsaasaanya y’amaanyi ne mu kuwummula. Okugeza, mu kugezesa ebisolo, oluvannyuma lw’okuweebwa Semaglutid, emiwendo gy’amasoboza g’ebisolo gyeyongera, era obuzito bw’omubiri gwabyo bwakendeera ne bwe kiba nti emmere gye baali balya yasigala nga bwe yali, ekiraga nti Semaglutid akola kinene mu kuddukanya obuzito ng’eyongera ku nsaasaanya y’amaanyi.
Okulungamya enkyukakyuka y’amasavu
Semaglutid era erina ekikolwa eky’okulungamya ku nkyukakyuka y’amasavu. Kiyinza okutumbula okumenya amasavu, okukendeeza ku kukola amasavu, n’okuziyiza okutereka amasavu. Mu kibumba, Semaglutid eyinza okuziyiza emirimu gy’enziyiza nga fatty acid synthase, bwe kityo n’ekendeeza ku kukola asidi w’amasavu. Okugatta ku ekyo, mu bitundu by’amasavu, Semaglutid eyinza okutumbula okumenya kw’amasavu, okwongera okufulumya asidi z’amasavu ez’obwereere, n’okukwanguyiza okuyingira kwazo mu mitochondria okumenyaamenya okw’okwokya, bwe kityo n’ekendeeza ku kutereka amasavu. Okunoonyereza kulaga nti oluvannyuma lw’ekiseera nga bajjanjabwa eddagala lya Semaglutid, amasavu mu mubiri gw’abalwadde naddala mu bitundu by’omubiri (visceral fat) gakendeera. Kino tekikoma ku kuyamba mu kugejja wabula era kirina kinene kye kikola ku kulongoosa obulwadde bw’okukyusakyusa emmere n’okukendeeza ku bulabe bw’endwadde z’emisuwa.
Okukozesa Semaglutid mu kuddukanya obuzito
Ku balwadde abagejjulukuka oba abagejjulukuka nga bawerekerwako endwadde ezikwatagana nabyo
Semaglutid erina omuwendo omutegeerekeka ogugenderera okuddukanya obuzito. Ku balwadde abagejjulukuka nga balina BMI ≥30 kg/m² oba abalwadde abagejjulukuka nga balina BMI ≥27 kg/m² era waakiri embeera emu eyeekuusa ku buzito (nga puleesa, ssukaali ow’ekika eky’okubiri, oba hypercholesterolemia), ddagala ddungi eriweweeza ku buzito. Omuddirirwa gwa STEP ogw’okugezesebwa mu malwaliro gwalaga okugejja okw’amaanyi mu balwadde abajjanjabiddwa. Mu kunoonyereza kwa STEP 1, abalwadde abajjanjabwa baatuuka ku kugejja kwa wakati nga 15% mu wiiki 68, ate ekibinja kya placebo kyakendeera ebitundu nga 2.4% byokka. Ebivudde mu kunoonyereza kuno biraga nti esobola okuyamba abalwadde abagejjulukuka oba abagejjulukuka abalina embeera ezikwatagana okutuuka ku kugejja okw’amaanyi era okw’olubeerera, okulongoosa ebiva mu bulamu, n’okukendeeza ku bulabe bw’endwadde ezeekuusa ku mugejjo.
Nga bigattiddwa wamu n‟okuyingira mu nsonga z‟obulamu
Mu kuddukanya obuzito, Semaglutid etera okukozesebwa ng’egatta wamu n’okuyingira mu bulamu, omuli okukendeeza ku kalori z’olya n’okwongera okukola emirimu gy’omubiri. Singa okugejja kwesigama ku ddagala lyokka nga tekukyusizza mize gya bulamu egitabeera bulungi, ebivaamu bitera obutabeera bya lubeerera. Enkola zombi bwe zigatta zirina ekikolwa eky’okukwatagana: eddagala lino linyigiriza okwagala okulya n’okwongera ku nsaasaanya y’amaanyi, ate okufuga emmere kukendeeza ku kalori eziyingira n’okwongera okukola emirimu gy’omubiri kyongera okutumbula ensaasaanya y’amaanyi, ekivaako okugejja ennyo era okuwangaala. Okugeza, mu nkola ezimu ez’obujjanjabi, abalwadde abagoberera enteekateeka y’emmere erimu kalori entono eyakolebwa omukugu mu by’endya ne bongera ku budde bwabwe obw’okukola dduyiro ow’omukka buli wiiki nga bafuna obujjanjabi batuuka ku biva mu kugejja ebirungi ennyo okusinga abo abeesigama ku ddagala oba okuyingira mu bulamu bwokka. Enkola eno ey’okugatta eggumiza obukulu bw’okuddukanya obuzito mu ngeri ey’enjawulo mu kuddukanya obuzito, okuyamba abalwadde okuteekawo obulamu obulungi n’okutuuka ku kufuga obuzito obw’ekiseera ekiwanvu.
Mu bufunzi
Semaglutid eraga obusobozi obw’amaanyi mu kujjanjaba ssukaali n’okuddukanya obuzito. Mu bujjanjabi bwa sukaali, bufuga bulungi glucose mu musaayi okuyita mu nkola eziwera, erongoosa enkola y’obutoffaali bwa β, era asobola okukozesebwa ng’obujjanjabi bumu oba nga bugatta wamu n’eddagala eddala eritta ssukaali. Mu kuddukanya obuzito, kiziyiza okwagala okulya, kyongera okukozesa amaanyi, n’okutereeza enkola y’amasavu, ekigifuula esaanira abalwadde abagejjulukuka oba abagejjulukuka abalina embeera ezikwatagana nabyo. Bwe kigattibwa wamu n‟okuyingira mu nsonga z‟obulamu, kivaamu ebirungi n‟okusingawo.
Ensonda
[1] Salvador R, Moutinho CG, Sousa C, n’abalala. Semaglutid nga GLP-1 Agonist: Okumenyawo mu bujjanjabi bw’omugejjo[J]. Eddagala, 2025,18 (3).DOI: 10.3390 / ph18030399.
[2] Memon A, Tehrim M, Kumari B. Semaglutid: enkya empya eri abalwadde ba ssukaali[J]. Journal of ekibiina ekigatta abasawo mu Pakistan, 2023,73 (3): 721.DOI: 10.47391 / JPMA.7558.
[3] Colin IM, Gérard K M. Omulundi gumu buli wiiki 2.4 mg Semaglutid okuddukanya obuzito mu mugejjo: Ekikyusa omuzannyo?[J]. Touchrev Endocrinol, 2022, 18 (1): 35-42.DOI: 10.17925 / EE.2022.18.1.35.
[4] Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): eddagala eppya erikendeeza ku buzito erijjanjaba omugejjo obutawona[J]. Journal of Eddagala okunoonyereza, 2022,70 (1): 5-13.DOI: 10.1136 / jim-2021-001952.
[5] Mares AC, Chatterjee S, Mukherjee D. Semaglutid olw’okugejja n’okukendeeza ku bulabe bw’omutima mu mugejjo/omugejjo[J]. Endowooza eriwo kati mu by’omutima, 2022,37 (4): 350-355.DOI: 10.1097 / HCO.0000000000000955.
[6] Chudleigh RA, Bain S C. Empiso ya semaglutid okujjanjaba abantu abakulu abalina sukaali ow’ekika eky’okubiri[J]. Omukugu mu kwekenneenya eddagala mu bujjanjabi, 2020, 13 (7): 675-684.DOI: 10.1080 / 17512433.2020.1776108.
[7] Gomez-Peralta F, Abreu C. Profile ya semaglutide mu kuddukanya ssukaali ow’ekika eky’okubiri: dizayini, enkulaakulana, n’ekifo mu bujjanjabi[J]. Eddagala Des Devel Ther, 2019,13:731-738.DOI:10.2147/DDDT.S165372.
[8] Hedrington MS, Davis S N. Semaglutide emira mu kamwa okujjanjaba ssukaali ow’ekika eky’okubiri[J]. Endowooza y'abakugu ku ddagala, 2019,20 (2): 133-141.DOI: 10.1080 / 14656566.2018.1552258.
Ekintu ekiriwo okukozesebwa mu kunoonyereza kwokka:
